Literature DB >> 16545030

Differential diagnosis between borderline personality disorder and organic personality disorder following traumatic brain injury.

Jean Gagnon1, Marc-André Bouchard, Constant Rainville.   

Abstract

Organic personality disorder (OPD) is the traditional diagnostic category used to account for personality disturbances after traumatic brain injury (TBI). The recent use of Axis-II personality disorders, notably borderline personality disorder (BPD), has appeared in the TBI literature as an alternative to OPD. This would presumably offer a better description and understanding of the multiple clinical manifestations of these personality changes and disorders. This article offers a view that it is possible and fruitful to use both diagnoses in a complementary manner. An accurate recognition of the respective phenomenologies of both BPD and OPD is a key factor in achieving a differential diagnosis, including, if required, a dual diagnosis. The phenomenology of both conditions in reference to DSM-IV criteria is compared and illustrated through two clinical vignettes.

Entities:  

Mesh:

Year:  2006        PMID: 16545030     DOI: 10.1521/bumc.2006.70.1.1

Source DB:  PubMed          Journal:  Bull Menninger Clin        ISSN: 0025-9284


  3 in total

Review 1.  Rehabilitation treatments for adults with behavioral and psychosocial disorders following acquired brain injury: a systematic review.

Authors:  Raffaella Cattelani; Marina Zettin; Pierluigi Zoccolotti
Journal:  Neuropsychol Rev       Date:  2010-02-09       Impact factor: 7.444

2.  Neuropsychiatric changes following penetrating head injury in children.

Authors:  Jetan H Badhiwala; Janet R Blackham; Ratan D Bhardwaj
Journal:  Surg Neurol Int       Date:  2014-10-31

3.  Forensic psychiatric analysis of organic personality disorders after craniocerebral injury in Shanghai, China.

Authors:  Beixu Li; Youxin Fang; Junyi Lin; Xueyan Chen; Chenhu Li; Meng He
Journal:  Front Psychiatry       Date:  2022-07-29       Impact factor: 5.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.